Effects of PDE4 Pathway Inhibition in Rat Experimental Stroke

PURPOSE: The first genomewide association study indicated that variations in the phosphodiesterase 4D (PDE4D) gene confer risk for ischemic stroke. However, inconsistencies among the studies designed to replicate the findings indicated the need for further investigation to elucidate the role of the...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Fan Yang (Author), Rachita K Sumbria (Author), Dong Xue (Author), Chuanhui Yu (Author), Dan He (Author), Shuo Liu (Author), Annlia Paganini-Hill (Author), Mark Fisher (Author)
বিন্যাস: গ্রন্থ
প্রকাশিত: Frontiers Media S.A., 2014-08-01T00:00:00Z.
বিষয়গুলি:
অনলাইন ব্যবহার করুন:Connect to this object online.
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8523cf5d1f2346dba1de29ddc9e708d4
042 |a dc 
100 1 0 |a Fan Yang  |e author 
700 1 0 |a Rachita K Sumbria  |e author 
700 1 0 |a Dong Xue  |e author 
700 1 0 |a Chuanhui Yu  |e author 
700 1 0 |a Dan He  |e author 
700 1 0 |a Shuo Liu  |e author 
700 1 0 |a Annlia Paganini-Hill  |e author 
700 1 0 |a Mark Fisher  |e author 
245 0 0 |a Effects of PDE4 Pathway Inhibition in Rat Experimental Stroke 
260 |b Frontiers Media S.A.,   |c 2014-08-01T00:00:00Z. 
500 |a 10.18433/J3S02V 
500 |a 1482-1826 
520 |a PURPOSE: The first genomewide association study indicated that variations in the phosphodiesterase 4D (PDE4D) gene confer risk for ischemic stroke. However, inconsistencies among the studies designed to replicate the findings indicated the need for further investigation to elucidate the role of the PDE4 pathway in stroke pathogenesis. Hence, we studied the effect of global inhibition of the PDE4 pathway in two rat experimental stroke models, using the PDE4 inhibitor rolipram. Further, the specific role of the PDE4D isoform in ischemic stroke pathogenesis was studied using PDE4D knockout rats in experimental stroke. METHODS: Rats were subjected to either the ligation or embolic stroke model and treated with rolipram (3mg/kg; i.p.) prior to the ischemic insult. Similarly, the PDE4D knockout rats were subjected to experimental stroke using the embolic model. RESULTS: Global inhibition of the PDE4 pathway using rolipram produced infarcts that were 225% (p<0.01) and 138% (p<0.05) of control in the ligation and embolic models, respectively. PDE4D knockout rats subjected to embolic stroke showed no change in infarct size compared to wild-type control. CONCLUSIONS: Despite increase in infarct size after global inhibition of the PDE4 pathway with rolipram, specific inhibition of the PDE4D isoform had no effect on experimental stroke. These findings support a role for the PDE4 pathway, independent of the PDE4D isoform, in ischemic stroke pathogenesis.   This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy & Pharmaceutical Sciences, Vol 17, Iss 3 (2014) 
787 0 |n https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/21823 
787 0 |n https://doaj.org/toc/1482-1826 
856 4 1 |u https://doaj.org/article/8523cf5d1f2346dba1de29ddc9e708d4  |z Connect to this object online.